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Background: Renal cell carcinoma or RCC is one of the common and most lethal urological cancers, with 40% of
the patients succumbing to death because of metastatic progression of the disease. Treatment of metastatic RCC
remains highly challenging because of its resistance to chemotherapy as well as radiotherapy, besides surgical
resection. Whereas RCC comprises tumors with differing histological types, clear cell RCC remains the most
common. A major problem in the clinical management of patients presenting with localized ccRCC is the inability
to determine tumor aggressiveness and accurately predict the risk of metastasis following surgery. As a measure
to improve the diagnosis and prognosis of RCC, researchers have identified several molecular markers through
a number of techniques. However the wealth of information available is scattered in literature and not easily
amenable to data-mining. To reduce this gap, this work describes a comprehensive repository called Renal
Cancer Gene Database, as an integrated gateway to study renal cancer related data.
Findings: Renal Cancer Gene Database is a manually curated compendium of 240 protein-coding and 269 miRNA
genes contributing to the etiology and pathogenesis of various forms of renal cell carcinomas. The protein
coding genes have been classified according to the kind of gene alteration observed in RCC. RCDB also includes
the miRNAsdysregulated in RCC, along with the corresponding information regarding the type of RCC and/or
metastatic or prognostic significance. While some of the miRNA genes showed an association with other types
of cancers few were unique to RCC. Users can query the database using keywords, category and chromosomal
location of the genes. The knowledgebase can be freely accessed via a user-friendly web interface at http://www.
juit.ac.in/attachments/jsr/rcdb/homenew.html.
Conclusions: It is hoped that this database would serve as a useful complement to the existing public resources
and as a good starting point for researchers and physicians interested in RCC genetics.
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Background
Renal cell carcinoma (RCC) represents a heterogeneous
group of tumors differing in genetic background,
responses to surgical and medical therapy and progno-
ses. It accounts for 3% of adult malignancy and results
in over 100000 deaths worldwide annually [1]. It is the
one of the leading causes of cancer deaths in Western
countries with steadily escalating incidence over the last
few decades [2]. RCC is classified based on morpho-
logical and genetic differences. This classification distin-
guishes metanephric adenoma oncocytoma and papillary
adenoma as benign tumors from the clear cell (ccRCC),Correspondence: jayashree_ramana@yahoo.co.in
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reproduction in any medium, provided the orpapillary/chromophilic, chromophobic (chRCC) and col-
lecting duct RCC. This classification is important be-
cause of its prognostic implications. ccRCC is the most
common and accounts for 70% of RCCs. RCC is diag-
nosed through imaging studies including CT and ultra-
sound, but kidney biopsy is an invasive technique that
might result in complications and would not provide
accurate diagnosis in certain situations. For early presen-
tations, surgical extirpation through nephrectomy pro-
vides an effective treatment, but patients usually present
at advanced stages, leading to poor outcomes. Even for
patients without metastatic spread who undergo neph-
rectomy, metastatic recurrence is frequent. Apart from
surgery, RCC is resistant to chemotherapy and radio-
therapy. Cytokine therapy, which is reserved for patients
with advanced disease, can produce partial responses in
10%–15% and durable remissions in 5% of the patients.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Classification of protein-coding genes in RCDB







Table 2 Classification of miRNA genes in RCDB
Category No. of miRNAs
1) chromocytoma vs oncocytoma 35
2) ccRCC vs papillary RCC 56
3) Poor vs Good prognosis 18
4) ccRCC vs normal kidney 190
5) chRCC vs normal kidney 57
6) ccRCC vs chRCC 64
7) Metastatic vs Non-metastatic RCC 33
8) Primary vs Late metastasis 11
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http://www.biomedcentral.com/1756-0500/5/246The therapeutic approach to RCC is determined by
the probability of cure, which is related directly to the
stage or degree of tumor dissemination. An accurate as-
sessment of the individual risk of disease progression
and mortality after treatment is crucial to counsel
patients and plan individualized surveillance protocols.
Multiple studies have investigated the deregulation of
genes in renal carcinogenesis at the genomic, transcrip-
tomic as well as proteomic levels using a suite of
molecular profiling techniques [3]. These include cyto-
genetic studies [4], gene expression analyses through tis-
sue microarrays [5,6], serum proteomics [7], genomic
resequencing [8], and microRNA profiling [9] and have
yielded useful insights into RCC biology and clinical
presentation, and have led to a rich understanding of the
heterogeneity of this disease which greatly influences
prognostic decisions. Despite the voluminous data avail-
able on RCC, the information is rather sporadic and
scattered in literature.
In the last few years, a number of databases have
emerged with a central focus on a particular cancer type
as exemplified by Lung Cancer Database [10], Oral Can-
cer Database [11], Breast Cancer Gene Database [12],
Cervical Cancer Database [13] etc., however there is no
report of any such database for RCC. This work
describes the development of the Renal Cancer Gene
Database (RCDB) that catalogs the protein-coding and
miRNA genes known to be involved in renal carcinogen-
esis as evidenced by biomedical literature. Due to its
specific focus on RCC, unlike dbDEMC [14] and miR2-
Disease [15], it provides a far broader coverage of the
miRNAsdysregulated in RCC. It incorporates informa-
tion regarding the relevance of miRNAs to molecular
classification of renal tumors (neoplasms) based on
tumor type, metastatic status or prognosis group. This
provides an additional advantage over other databases
like miR2disease. Many of the protein-coding and
miRNA genes in RCDB are useful prognostic and diag-
nostic markers and are therefore clinically relevant.
These may also serve as therapeutic targets.
Construction and content
RCDB contains information on RCC-implicated genes
compiled from research articles indexed in PubMed. The
PubMed database was queried with different keywords
like renal cell carcinoma, renal cancer or tumor etc. and
the articles retrieved were manually scrutinized to win-
now the genes affecting the etiology of RCC. The final
lists of 240 protein-coding and 269 miRNA genes were
identified in this way and used to populate the database.
The former were grouped into following six categories
(Table 1) based on the kind of gene alteration observed
in RCC: 1) (silencing/downregulation through) Methyla-
tion, 2) Overexpression, 3) Downregulation, 4) Mutationand 5) Translocation and 6) Unclassified. The latter (miR-
NAs) were categorized according to their differential ex-
pression in the different types of RCC. This classification
scheme (Table 2) includes differential expression in: 1)
chromocytoma vs oncocytoma 2) ccRCC vs papillary RCC
3) Poor vs Good prognosis 4) ccRCC vs normal kidney 5)
chRCC vs normal kidney 6) ccRCC vs chRCC 7) Meta-
static vs Non-metastatic RCC 8) Primary vs Late metas-
tasis. There exist few overlaps of miRNAs within these
categories. RCDB is implemented as a MySQL database
and the web-interface built in PHP.Utility and discussion
The web interface query form allows users to query the
protein coding genes from database using keyword, the
class and the chromosome number (Figure 1a). This
retrieves a list of genes (Figure 1b) where each gene
entry is further linked (Figure 1c) to its specific details
comprising its gene, nucleotide and protein accession
numbers, its chromosomal location as well as its involve-
ment in RCC and the PubMed records corroborating
the same. The miRNAs can also be browsed in a similar
way. The miRNA entries are linked to miRBase [16] wher-
ever available. The ViroBLAST [17] tool searches a user-
defined query sequence against the sequences available
in the database. This offers the additional advantage of
parsing the results according to E-value or score chosen
by the user.
Figure 1 Illustration of RCDB. (a) The web interface for data query and retrieval. (b) The query form retrieves the list of genes as required by
the query. (c) Each gene in the list is linked to its specific details.
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http://www.biomedcentral.com/1756-0500/5/246RCDB provides a comprehensive compilation of informa-
tion obtained from published RCC research, complemented
with the information from public databases like Swis-
sprot, Refseq etc. It would allow the users in performing
comparative studies, e.g. to deduce the genes that are
shared with other cancers as well as the ones which are
unique to RCC. This analysis was performed for miRNA
genes in RCDB by surveying the literature for the
involvement of these miRNAs in different cancers (Add-
itional file 1). While most of the miRNAs were found to
be reported in other types of malignancies, few were
unique to RCC. The latter included miR455, miR219,
miR509, miR627, miR648, miR510, miR379, miR136,
miR376b, miR154, miR551b, miR514, miR383, miR453,
miR582, miR450, miR425, miR365-1 etc.
Conclusion
RCDB has been developed as an integrated information
source to assist the research efforts of scientists and clin-
icians working on renal carcinoma. Besides providing a
panoramic overview of RCC, it facilitates thorough ex-
position of each gene by providing hyperlinks to relevant
PubMed records. In future, RCDB would be updated
and additional data incorporated. It is anticipated that
RCDB would serve as a valuable resource to the scien-
tific community.Availability and requirements
Project home page: http://www.juit.ac.in/attachments/
jsr/rcdb/homenew.html.
Additional file
Additional file 1: A comparison of miRNAs common and unique to
RCC and other cancers.
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